EBV-positive LMP1-mediated Signal Pathway in Nasopharyngeal Carcinoma

  • Xiaohui Li Otolaryngology Department, Hospital (T.C.M) Affiliated to Southwest Medical University
  • Ji Yin Otolaryngology Department, Hospital (T.C.M) Affiliated to Southwest Medical University
  • Sen Li Spinal Surgery Department, Hospital (T.C.M) Affiliated to Southwest Medical University
  • Wenjian Hu Otolaryngology Department, Hospital (T.C.M) Affiliated to Southwest Medical University
Article ID: 2015
70 Views, 19 PDF Downloads
DOI: https://doi.org/10.18282/l-e.v9i5.2015
Keywords: Epstein-Barr virus (EBV), Latent membrane protein 1 (LMP1), Nasopharyngeal Carcinoma (NPC), Signaling pathway

Abstract

Nasopharyngeal carcinoma (NPC) is one of the main cancers and death factors of otorhinolaryngological malignant tumors. A number of studies have shown that the occurrence and development of NPC is clearly related to Epstein-Barr virus (EBV) infection. Among the few proteins expressed by EBV, latent membrane protein 1 (LMP1) is considered to be a protein with the function of oncogenes, because it can make the epithelium tend toward malignant transformation; therefore LMP1 plays an important role in the occurrence and development of NPC, and is also considered to be the oncogene of EBV. LMP1 can further affect cell migration and apoptosis by participating in multiple intracellular signal transduction pathways, which is closely related to a variety of lymphoid tissue diseases and malignant tumors; nasopharyngeal carcinoma is no exception. This article reviews the signal pathways mediated by LMP1 in NPC.

References

[1] Liu HD, Zheng H, Duan Z, et al. LMP1-augmented kappa intron enhancer activity contributes to up regulation expression of Ig kappa light chain via NF-kappa B and AP-1 pathways in nasopharyngeal carcinoma cells[J]. Mol Cancer 2009 Oct 27;8, doi:10.1186/1476-4598-8-92.

[2] Tao YG, Tan YN, Liu YP, et al. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner[J]. Cell Signal,2004,16(7) 781-790.

[3] Li Z, Zhou Z. LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance. Am J Cancer Res 2020;107(7).

[4] Yang CF, Yang GD, EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop. Oncogene 2016 06 30;3526(26).

[5] Pang JHS, Yen JH, Wu HT, et al. Gallic Acid Inhibited Matrix Invasion and AP-1/ETS-1-Mediated MMP-1 Transcription in Human Nasopharyngeal Carcinoma Cells [J]. International Journal of Molecular Sciences, Int J Mol Sci 2017 Jun 24; 187(7).

[6] Hsin CH, Huang CC, Chen PN, et al. Rubus idaeus Inhibits Migration and Invasion of Human Nasopharyngeal Carcinoma Cells by Suppression of MMP-2 through Modulation of the ERK1/2 Pathway. [J]. Am J Chin Med 2017; 457(7).

[7] Mainou BA, Everly DN Jr, Raab-Traub N. Unique Signaling Properties of CTAR1 in LMP1-Mediated Transformation [J]. J Virol 2007 Sep;8118(18).

[8] Dawson CW, LaverickL, Morris MA. Epstein-Barr virus-encoded LMP1 regulate sepithelial cell motility and invasion via the ERK-MAPK pathway.

[9] Lo AK, Lo KW. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells. J Pathol 2013 Jul;2303(3).

[10] Eliopoulos AG, Young LS. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 1998 Apr 02;1613(13).

[11] Zhang Z, Yu X. LMP1-positive extra cellular vesicles promote radio resistance in nasopharyngeal carcinoma cells through P38 MAPK signaling.10.1002/cam4.2506.

[12] Mullen MK, Gonzalez-Perez RR. Leptin-Induced JAK/ STAT Signaling and Cancer Growth. Vaccines (Basel) 2016 Jul 26;43(3).

[13] Vaysberg M, Lambert SL, Krams SM et al, Activation of the JAK/STAT pathway in Epstein Barr virus+ -associated posttransplantlymphoproliferative disease: role of interferon gamma[J]. Am J Transplant 2009 Oct;910(10).

[14] Zheng P, Chen X. Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling. Cancer Sci. 2020 Jan;1111(1).

[15] O’Neil JD, Owen TJ, et al. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol 2008 Nov;89.

[16] Yang L, Liu L, Xu Z etal.EBV-LMP1 targeted DNAzyme enhance sadio sensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.

[17] Ding RR, Yuan JL. Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation. Onco Targets Ther 2019.

[18] Fang W, Zhang J. EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy. Oncotarget 2014 Dec 15;523(23).

[19] Xiang YP, Xiao T. Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2/Erk-1/2 signaling pathway. Cell Death Dis 2020 Aug 27;118(8).

Published
2021-05-19
How to Cite
Li, X., Yin, J., Li, S., & Hu, W. (2021). EBV-positive LMP1-mediated Signal Pathway in Nasopharyngeal Carcinoma. Learning & Education, 9(5), 31-33. https://doi.org/10.18282/l-e.v9i5.2015
Issue
Vol. 9 No. 5 (2020)

Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution-Noncommercial 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, that the work is not used for commercial purposes, and that in the event of reuse or distribution, the terms of this license are made clear. With this license, the authors hold the copyright without restrictions and are allowed to retain publishing rights without restrictions as long as this journal is the original publisher of the articles.